- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/72 - ReceptorsCell surface antigensCell surface determinants for hormones
Patent holdings for IPC class C07K 14/72
Total number of patents in this class: 963
10-year publication summary
|
43
|
74
|
67
|
85
|
68
|
63
|
72
|
64
|
57
|
55
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1157 |
39 |
| The Regents of the University of California | 20245 |
20 |
| Vib VZW | 883 |
18 |
| Vrije Universiteit Brussel | 513 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4417 |
17 |
| The Board of Trustees of the Leland Stanford Junior University | 6522 |
13 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2206 |
13 |
| Nxera Pharma UK Limited | 172 |
13 |
| Amgen Inc. | 4161 |
10 |
| Hanmi Pharm. Co., Ltd. | 576 |
10 |
| Heptares Therapeutics Limited | 74 |
10 |
| Rhythm Pharmaceuticals, Inc. | 80 |
10 |
| Massachusetts Institute of Technology | 10124 |
9 |
| Board of Regents, The University of Texas System | 5921 |
9 |
| President and Fellows of Harvard College | 6028 |
9 |
| Duke University | 3105 |
9 |
| Cornell University | 3353 |
9 |
| H. Lundbeck A/S | 1237 |
9 |
| Asterion Limited | 23 |
8 |
| The Johns Hopkins University | 5746 |
7 |
| Other owners | 703 |